Related Experiment Video
Updated: Jul 16, 2025

09:12
Surface Functionalization of Hepatitis E Virus Nanoparticles Using Chemical Conjugation Methods
Published on: May 11, 2018
6.9K
Virus-like particles nanoreactors: from catalysis towards bio-applications
Yuqing Su1, Beibei Liu1, Zhenkun Huang1
1Fujian Provincial Key Laboratory of Innovative Drug Target Research, School of Pharmaceutical Sciences, Xiamen University, Xiamen 361102, China. aijieliu@xmu.edu.cn.
Journal of Materials Chemistry. B
|September 12, 2023
Summary
Virus-like particles (VLPs) are nature's nanocarriers, offering stable, precise structures for advanced nanoreactors. This review explores their catalytic applications and potential as artificial organelles in biomedicine.
Area of Science:
- Biotechnology and Nanotechnology
- Catalysis
- Biomedical Engineering
Background:
- Virus-like particles (VLPs) are naturally occurring, self-assembled supramolecular structures.
- VLPs possess advantageous properties such as nanoscale precision, monodispersity, and high stability.
- These characteristics make VLPs suitable for use as nanocarriers in various applications.
Purpose of the Study:
- To review the current progress of virus-like particles (VLPs)-based nanoreactors.
- To explore the physicochemical properties of common virus particles for catalytic applications.
- To discuss the self-assembly of VLP nanoreactors, their role as artificial organelles, and potential biomedical uses.
Main Methods:
- Literature review of VLP-based nanoreactors.
- Analysis of VLP physicochemical properties relevant to catalysis.
- Summary of VLP nanoreactor self-assembly and hierarchical structures.
Main Results:
- VLPs serve as effective nanocarriers, protecting and enriching catalysts for improved reactions.
- VLP nanoreactors offer confined environments, preventing interference from bulk solutions.
- Emerging applications include VLP nanoreactors functioning as artificial organelles with potential biomedical relevance.
Conclusions:
- VLP-based nanoreactors represent a significant advancement in catalysis and nanotechnology.
- Further research into VLP nanoreactors holds promise for novel biomedical applications.
- The review provides insights into current findings and future directions in the field.
Related Concept Videos
Ribozymes
12.3K
The term ribozyme is used for RNA that can act as an enzyme. Ribozymes are mainly found in selected viruses, bacteria, plant organelles, and lower eukaryotes. Ribozymes were first discovered in 1982 when Tom Cech’s laboratory observed Group I introns acting as enzymes. This was shortly followed by the discovery of another ribozyme, Ribonulcease P, by Sid Altman’s laboratory. Both Cech and Altman received the Nobel Prize in chemistry in 1989 for their work on ribozymes.
Ribozymes can...
Ribozymes can...
12.3K
Subviral Agents
41
Subviral agents are infectious entities that resemble viruses but lack one or more viral components, such as a capsid or essential replication machinery. These agents include viroids, prions, and satellites, each possessing distinct structural and functional characteristics that influence their mode of infection and replication.Viroids are the simplest subviral agents, consisting of circular, single-stranded RNA molecules without a protein coat. They exclusively infect plants, relying entirely...
41

